Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The genetics of multiple sclerosis.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
Very early MS -- insights from MRI.
Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Treatment of HIV and Risk of Multiple Sclerosis.
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE).
Can we safely target the WNT pathway?
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
The autonomic balance predicts cardiac responses after the first dose of fingolimod.
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Clinical assessment of noninvasive intracranial pressure absolute value measurement method.
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
High-dose cyclophosphamide in the treatment of multiple sclerosis.
Newly diagnosed multiple sclerosis in state of Qatar.
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.
Pregnancy in multiple sclerosis: a questionnaire study.
Pages
« first
‹ previous
…
150
151
152
153
154
155
156
157
158
…
next ›
last »